Parenteral Fish-Oil Emulsions in Critically Ill COVID-19 Emulsions

Trial of a clinically approved parenteral fish‐oil emulsion providing an eicosapentaenoic acid/docosahexaenoic acid combination for the management of the hyperinflammatory state or “cytokine storm” found in some critically ill patients infected with COVID‐19.